3rd Drug Development Forum
October 1–3, 2018 | Hilton Boston Logan Airport Hotel
Executive-level networking for smarter partnerships and pipeline strategies, more effective development, and improved early research outcomes
FIERCEBIOTECH DRUG DEVELOPMENT FORUM
Where industry leaders set partnership and pipeline strategy
The FierceBiotech Drug Development Forum is an incomparable networking venue where hundreds of biotech C-suite decision makers tackle the greatest problems the industry faces in business development and early R&D.
Our all-new program features unprecedented depth on managing VC relationships, beating ambitious growth plans, developing your immuno-oncology business model, adapting to new regulatory and pricing realities, and maintaining competitive advantage after the next market downturn.
2018 Featured Speakers
Girish Aakalu
VP, Global Head of External Innovation
IPSEN
Roy Baynes
CMO, Senior Vice President, Head of Clinical Development
MERCK
David Berman
Senior Vice President, Immuno-Oncology Franchise
MEDIMMUNE
Lawrence Bloch
President
INFINITY PHARMACEUTICALS
Ramzi Dagher
Vice President, Worldwide Safety and Regulatory, and Regulatory Head, Europe and International
PFIZER
Nouhad Husseini
Vice President, Head of Business Development
REGENERON
Ravi Kiron
Head, BioPharma External Innovation
EMD SERONO
Agustin Melian
Senior Vice President, Global Medical Sciences
ALEXION PHARMACEUTICALS
Salim Mujais
Senior Vice President, Global Therapeutics Head, Specialty Pharma
ASTELLAS
Sridhar Ramaswamy
Vice President, Translational R&D
TESARO
Jeremy Sohn
Vice President, Global Head of Digital Business Development & Licensing
NOVARTIS
2018 KEYNOTE SPEAKERS
KEYNOTE: Pursue Breakthrough Approvals in Multiple Global Markets
TUESDAY, OCTOBER 2, 2018
MODERATOR: Eric Palmer, Editor, FIERCEMARKETS
Ramzi Dagher, Vice President, Worldwide Safety and Regulatory; Regulatory Head, Europe and International, PFIZER
Martine Zimmerman, Senior Vice President, Global Regulatory Affairs, ALEXION PHARMACEUTICALS
Roy Baynes, CMO, Senior Vice President, Head of Clinical Development, MERCK
Maria Fardis, CEO, IOVANCE
Fierce 15 winners: What does it take to be fierce in today's biotech market?
2018 SPONSORING ORGANIZATIONS
